MMR Vaccine Does Not Increase Risk of Crohn's Disease
The measles, mumps, and rubella (MMR) vaccine does not increase the risk of Crohn's disease (chronic inflammation of the intestine), finds a study in this week's British Medical Journal (BMJ).
It has been hypothesized that the MMR vaccine increases the risk of Crohn's disease, although the evidence for this is sparse. The study provides strong evidence against this theory and adds to the evidence that MMR vaccine is no less safe in this respect than the single measles vaccine.
Valerie Seagroatt, a statistician at Oxford University, analyzed national data on hospital admissions for Crohn's disease in children and adolescents over the 12 years from April 1991 to March 2003.
She plotted rates for narrow (three-year) age bands and compared rates for those born before and after the introduction of the vaccine. She found no increase in Crohn's disease associated with the introduction of the MMR vaccination program, providing strong evidence against the hypothesis that MMR vaccine increases the risk of Crohn's disease.
Reference: MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002 BMJ Volume 330, pp 1120-1
Source: BMJ
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
